Open API launched by myTomorrows
myTomorrows, global online facilitator of early access to investigational drugs, has introduced an openly accessible API to open up its comprehensive database of uniform information relating to clinical trials. Data on over 300,000 clinical trials, already accessible via its patient and physician centric website, can now be used by other organisations in their own environments. “Opening the myTomorrows database is a big push forward to make comprehensive and uniform information on clinical trials freely accessible to anybody who needs it. We hope to see further applications grow out of our data to better serve unmet medical needs globally and advance drug development” COO Robert Kraal explains, setting out myTomorrows’ hopes for the development. The interface can be used to search, filter, and download complete historic clinical trial records data accumulated from all the registries of the World Health Organization’s Primary Registry Network of medical trial registration partners. Potential applications include anything from ad-hoc queries by data scientists to patient trial screening to mobile health. “We have built the API with the intention of making it accessible for the largest group of stakeholders. Using a very simple approach, any programmer can directly access the data in a friendly human-readable format and structure” says Sander Nagtegaal, Chief Technical Officer at myTomorrows. For technical details, please visit the official documentation, the API terms of service or reach out to tech@mytomorrows.com directly.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
